Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.28 PLN | -2.56% | +5.56% | +10.14% |
28/05 | Novavis Group S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
26/04 | Novavis Group S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Its low valuation, with P/E ratio at 9.12 and 3.3 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's enterprise value to sales, at 5.29 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Renewable Energy Equipment & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.14% | 2Cr | - | ||
+8.57% | 153.97Cr | - | ||
+29.81% | 96Cr | C+ | ||
0.00% | 96Cr | C- | ||
+30.27% | 53Cr | - | ||
+13.86% | 47Cr | - | - | |
+12.00% | 45Cr | - | - | |
+18.97% | 16Cr | - | A | |
+27.14% | 16Cr | - | - | |
+4.71% | 13Cr | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NVG Stock
- Ratings Novavis Group S.A.